Диссертация (1154655), страница 25
Текст из файла (страница 25)
Mebazaa, M.B. Yilmaz, P. Levy, etal. // Eur Heart J. – 2015. – vol. 36. – p. 1958–1966.140. Mentz, R.J. Noncardiac Comorbidities and Acute Heart Failure Patients / R.J. Mentz,G.Felker // Heart Fail Clin. -2013. – vol. 9(3). - p. 359–vii.141. Mentz, R.J. Pathophysiology and clinical evaluation of acute heart failure / R.J.Mentz, C.M.
O'Connor // Nat Rev Cardiol. – 2016. – vol.13(1). –p.28-35.142. Metra, M. RELAX-AHF Investigators. Effect of serelaxin on cardiac, renal, andhepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) developmentprogram: correlation with outcomes / M. Metra, G.
Cotter, B.A. Davison et al. // J AmColl Cardiol. – 2013. –vol. 61. – p. 196–206.143. Metra, M. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxinin Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes/ M. Metra, et al. // J Am Coll Cardiol. – 2013. – vol.61.
–p.196 – 206.144. Michael, D. Drug - Induced Liver Injury / D. Michael, M.D. Leise, J. John, M.D.Poterucha and A.Jayant, M.D. Talwalkar // Mayo Clin Proc. – 2014. –vol. 89(1). – p. 95106.145. Millonig, G. Liver stiffness is directly influenced by central venous pressure / G.Millonig, S. Friedrich, S. Adolf, H. Fonouni, M. Golriz, A. Mehrabi, P. Stiefel, G. Poschl,M.W. Buchler, H.K.
Seitz, S. Mueller // J Hepatol. – 2010. – vol.52. – p.206-210.146. Ming, Z. Decreases in portal flow trigger a hepatorenal reflex to inhibit renal sodiumand water excretion in rats: Role of adenosine. Hepatology. – 2002. – vol.35(1). - p.167175.136147. Miyazawa, S. Leukocyte accumulation and changes in extra-renal organs duringrenal ischemia reperfusion in mice / S. Miyazawa, H. Watanabe, C. Miyaji, O. Hotta andT. Abo // Journal of Laboratory and Clinical Medicine. - 2002.
–vol.139(5). - p. 269-278.148. Moin, D.S. Serelaxin for the treatment of heart failure / D.S. Moin, M.W. Bloom, L.Papadimitriou, J. Butler // Expert Review of Cardiovascular Therapy. – 2016. – vol.14(6). – p. 667-675.149. Møller, S. Cirrhotic Multiorgan Syndrome / S. Møller, F. Bendtsen // Dig Dis Sci. –2015. – vol. 60(11). – p. 3209-3225. doi: 10.1007/s10620-015-3752-3.150. Morgan, D.J. Clinical pharmacokinetic and pharmacody - namics considerations inpatients with liver disease.
An update / D.J. Morgan, A.J. McLean // Clin Pharmacokinet.– 1995. – vol. 29. – p.370–391.151. Mullens, W. Elevated Intra-Abdominal Pressure in Acute Decompensated HeartFailure / W. Mullens, Z. Abrahams, H. Skouri, G. Francis, D. Taylor, R. Starling, E.Paganini and W. Tang // Journal of the American College of Cardiology. – 2008. – vol.51(3). – p. 300-306.152. Mullens, W. Prompt Reduction in Intra-Abdominal Pressure Following LargeVolume Mechanical Fluid Removal Improves Renal Insufficiency in RefractoryDecompensated Heart Failure / W. Mullens, Z.
Abrahams, G. Francis, D. Taylor, R.Starling and W. Tang // Journal of Cardiac Failure. – 2008. – vol.14(6). – p. 508-514.153. Myers, R.P. Cardiac hepatopathy: clinical, hemodynamic, and histologiccharacteristics and correlations / R.P. Myers, R. Cerini, R. Sayegh, R. Moreau, C. Degott,D. Lebrec, S.S. Lee // Hepatology. – 2003. – vol.37. – p. 393–400.154. Naschitz, J.E. Heart diseases affecting the liver and liver diseases affecting the heart/ J.E. Naschitz, G. Slobodin, R.J. Lewis, E. Zuckerman, D. Yeshurun // Am Heart J.
–2000. – vol.140. – p. 111–120.155. Nasser, M. Hyperacute drug-induced hepatitis with intravenous amiodarone: casereport and review of the literature / M. Nasser, T.R. Larsen, B. Waanbah, I. Sidiqi, P.A.McCullough // Drug Healthc Patient Saf. – 2013. – vol. 5. – p.191-198.156. Nikolaou, M. Liver function abnormalities, clinical profile, and outcome in acutedecompensated heart failure / M. Nikolaou, J. Parissis, M.B.
Yilmaz, M.F. Seronde, M.137Kivikko, S. Laribi, C. Paugam-Burtz, D. Cai, P. Pohjanjousi, P.F. Laterre, N. Deye, P.Poder, A. Cohen-Solal, A. Mebazaa // Eur Heart J. – 2013. – vol.34(10). – p.742-749.157. Nishi, H. Novel method of evaluating liver stiffness using transient elastography toevaluate perioperative status in severe heart failure / H. Nishi, K. Toda, S. Miyagawa, Y.Yoshikawa, S. Fukushima, M.
Kawamura, T. Saito, D. Yoshioka, T. Daimon, Y. Sawa //Circ J. – 2015. – vol.79(2). – p.391-397.158. Nistri, S. Relaxin induces mast cell inhibition and reduces ventricular arrhythmiasin a swine model of acute myocardial infarction / S.
Nistri, L. Cinci, A.M. Perna, E.Masini, R. Mastroianni, D. Bani // Pharmacol Res. – 2008. – vol. 57. – p. 43– 48.159. Ogawa, R. Clinical pharmacokinetics of drugs in patients with heart failure: anupdate (part 2, drugs administered orally) / R. Ogawa, J.M.
Stachnik, H. Echizen // ClinPharmacokinet. – 2014. – vol. 53(12). – p. 1083-1114.160. Ogawa, R. Clinical pharmacokinetics of drugs in patients with heart failure: anupdate (part 1, drugsadministered intravenously) / R. Ogawa, J.M. Stachnik, H. Echizen// Clin Pharmacokinet. – 2013. – vol. 52(3). – p.169-185.161. Okada, A. Prognostic Value of Prothrombin Time International Normalized Ratio inAcute Decompensated Heart Failure. A Combined Marker of Hepatic Insuf ciency andHemostatic Abnormality /A.
Okada, Y. Sugano, T. Nagai,S. Takashio, S.Honda, Y.Asaumi, T. Aiba, T.Noguchi // Circulation Journal. – 2016. – vol. 80. – p. 913–923.162. Opie, L. Drugs for the Heart / L. Opie, B. Gersh // 8th ed. New York. NY: Elsevier.– 2013.163. Parikh, A. Relaxin suppresses atrial fibrillation by reversing fibrosis and myocytehypertrophy and increasing conduction velocity and sodium current in spontaneouslyhypertensive rat hearts / A. Parikh, D.
Patel, C.F. Mctiernan et al. // Circ Res. – 2013. –vol. 113. – p. 313–321.164. Parissis, J.T. Cardio-reno-hepatic interactions in acute heart failure: the role of γglutamyl transferase / J.T. Parissis, D. Farmakis, C. Andreoli, P. Rafouli-Stergiou, G.Ambrosio, M. Anastasiou-Nana, G. Filippatos // Int J Cardiol. -2014. – vol.173(3). – p.556-557. - doi: 10.1016/j.ijcard.2014.03.127.165. Park, S. Cytokines induce small intestine and liver injury after renal ischemia or138nephrectomy / S. Park, S.
Chen, M. Kim, K. Brown, J. Kolls, V. D'Agati and H. Lee //Lab Invest. - 2010. – vol.91(1). -p.63-84.166. Patel, M.R. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation / M.R.Patel, K.W. Mahaffey, J. Garg, et al. // N Engl J Med. - 2011. – vol. 365.
– p. 883– 891.167. Perazzo, H. Factors That Could Impact on Liver Fibrosis Staging by TransientElastography / H. Perazzo, V. G. Veloso, B. Grinsztejn, C. Hyde, R. Castro // Int JHepatol. – 2015. – vol. 6. – p. 624596. doi: 10.1155/2015/624596.168. Poelzl, G. Cardiohepatic syndrome / G. Poelzl, J. Auer // Curr Heart Fail Rep. –2015. – vol.12(1). – p.68-78.169. Pugh, R.N. Transectino of the oesophagus for bleeding oesophageal varices / R.N.Pugh, I.M.
Murray-Lyon, J.L. Dawson, M.C. Pietroni, R. Williams // Br J Surg. – 1973.– vol. 60. – p. 646–649.170. Raichlin, E. Combined heart and liver transplantation: a single-center experience /E. Raichlin, R. Daly, C. Rosen, et al. // Transplantation. – 2009. – vol. 88(2). – p. 219226.171. Raleigh, J.M. Relaxin' the Heart: A Novel Therapeutic Modality / J.M.
Raleigh, S.Toldo, A. Das, A. Abbate, F. Salloum // J Cardiovasc Pharmacol Ther. – 2016. – vol.21(4). – p. 353-362.172. Raurich, J.M. Hypoxic hepatitis in critically ill patients: incidence, etiology and riskfactors for mortality / Raurich JM, Llompart-Pou JA, Ferreruela M, et al. // J Anesth. –2011. – vol. 25. – p.50–56. doi: 10.1007/s00540-010-1058-3.173. Rodighiero, V.
Effects of liver disease on pharmacokinetics. An update. ClinPharmacokinet. – 1999. – vol.37. – p.399–431.174. Ronco, C. Cardio-renal syndromes: report from the consensus conference of theAcute Dialysis Quality Initiative / Ronco C., et al. // European Heart Journal. – 2009. –vol.31(6). -p.703-711. - doi: 10.1093/eurheartj/ehp507.175. Rowland, M. Clinical Pharmacokinetics. Concepts and Applications. 3rd edition /M.
Rowland, T.N. Tozer // Media, PA: Lippincott Williams & Wilkins, 1995.176. Russell, S.D. Renal and hepatic function improve in advanced heart failure patientsduring continuous- flow support with the Heart Mate II left ventricular assist device / S.D.139Russell, J.G. Rogers, C.A. Milano, et al. // Circulation. – 2009. – vol.120. – p. 2352-2357.177. Saab, S. MELD score predicts 1-year patient survival post-orthotopic livertransplantation / S.
Saab, V. Wang, A.B. Ibrahim, F. Durazo, S. Han, D.G. Farmer, H.Yersiz, M. Morrisey, L.I. Goldstein, R.M. Ghobrial, R.W. Busuttil // Liver Transpl. –2003. – vol. 9. – p. 473 – 476.178. Sagir, A. Transient elastography is unreliable for detection of cirrhosis in patientswith acute liver damage / A. Sagir, A. Erhardt, M. Schmitt, D. Haussinger // Hepatology.– 2008. – vol.47. – p.592-595.179.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
